Skip to content

Investigation of cough sensitivity and risk factors in patients with stable chronic obstructive pulmonary disease

Investigation of cough sensitivity and risk factors in patients with stable chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070490
Enrollment
Unknown
Registered
2023-04-13
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease (COPD)

Interventions

COPD with high cough sensitivity group:N/A
COPD with low cough sensitivity group:N/A

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. COPD is diagnosed according to the Global Initiative Criteria for Chronic Obstructive Pulmonary Disease (GOLD2020); Specific standards: (1) A long history of smoking or occupational dust inhalation; (2) Suffering from dyspnea, chronic cough or expectoration; (3) FEV1/FVC value < 0.70 after bronchodilator inhalation; 3. No symptoms of respiratory infection or exacerbation in the 1 month prior to the study; 4. Willing to sign written informed consent and comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating patients; 2. Complicated with other lung diseases such as asthma, bronchiectasis, pulmonary interstitial diseases, lung tumors, pulmonary resection, etc.; 3. Complicated with severe cardiac insufficiency, severe liver and kidney dysfunction, mental and cognitive dysfunction, hearing and communication dysfunction, etc.

Design outcomes

Primary

MeasureTime frame
Minimum inhalation concentration of capsaicin solution corresponding to induced cough >=2 times;Minimum inhalation concentration of capsaicin solution corresponding to induced cough >=5 times;

Secondary

MeasureTime frame
Cough visual analogue scale score;Hull airway reflux questionnaire;Chronic obstructive pulmonary disease assessment test;Modified version of the medical research council dyspnea scale;

Countries

China

Contacts

Public ContactYu Li

Shanghai Tongji Hospital

96778@tongji.edu.cn+86 13816699078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026